NAMS MENOPAUSE
CERTIFICATION EXAM (MSCP)
NEWEST 2026 ACTUAL | EXAM
QUESTIONS AND CORRECT
VERIFIED ANSWERS (GRADED A+)
Question 1: What is the primary cause of vasomotor symptoms during
menopause?
A) Elevated estrogen levels
B) Decreased estrogen leading to a narrowed thermoregulatory set point
C) Increased progesterone
D) Rising FSH levels
Correct Answer: B
Rationale: Vasomotor symptoms like hot flashes result from estrogen
deficiency, which narrows the thermoregulatory zone in the hypothalamus.
Slight increases in core body temperature are then perceived as excessive
heat, triggering sweating and vasodilation .
Question 2: A 52-year-old woman with a history of breast cancer has 8 hot
flashes daily. What is the first-line non-hormonal therapy recommended by
NAMS?
, A) Vitamin E
B) SSRIs or SNRIs
C) Gabapentin
D) Black cohosh
Correct Answer: B
Rationale: SSRIs (like paroxetine) and SNRIs are recommended as first-line
non-hormonal treatments for moderate-to-severe VMS, especially in
women with contraindications to hormone therapy .
Question 3: Which strategy helps reduce VTE risk with hormone therapy?
A) Using oral estrogen
B) Using transdermal estrogen
C) Adding a progestogen
D) Lowering the dose of progestogen
Correct Answer: B
Rationale: Transdermal estrogen avoids first-pass hepatic metabolism,
resulting in a lower impact on coagulation factors and a lower VTE risk
compared to oral estrogen .
Question 4: A woman in late perimenopause has 60+ day intervals
between periods. What is the expected endometrial thickness on TVUS in
the absence of abnormal bleeding?
A) Greater than 16 mm
, B) Less than 5 mm
C) 4-8 mm
D) Greater than 10 mm
Correct Answer: C
Rationale: In perimenopausal women without abnormal bleeding, an
endometrial thickness of 4-8 mm is generally considered normal and does
not require further evaluation .
Question 5: The "climacteric phase" refers to:
A) The final menstrual period
B) The period of endocrinologic and psychologic changes around the time
of menopause
C) The perimenopause only
D) The postmenopausal period
Correct Answer: B
Rationale: The climacteric phase encompasses the transition from the
reproductive to the non-reproductive stage, including the endocrinologic,
somatic, and psychologic changes that occur .
Question 6: What is the median age of natural menopause?
A) 45 years
B) 48 years
C) 51 years
, D) 55 years
Correct Answer: C
Rationale: The median age of natural menopause is approximately 51
years .
Question 7: Which is the most effective treatment for moderate-to-severe
hot flashes?
A) Calcium
B) Hormone therapy
C) Iron supplements
D) Antibiotics
Correct Answer: B
Rationale: Estrogen therapy is the most effective treatment for vasomotor
symptoms .
Question 8: Which laboratory finding supports menopause?
A) Low FSH
B) Elevated FSH (≥25 IU/L)
C) High progesterone
D) High prolactin
Correct Answer: B
Rationale: Elevated FSH reflects reduced ovarian feedback due to low
estrogen levels and is a useful marker supporting menopause .
CERTIFICATION EXAM (MSCP)
NEWEST 2026 ACTUAL | EXAM
QUESTIONS AND CORRECT
VERIFIED ANSWERS (GRADED A+)
Question 1: What is the primary cause of vasomotor symptoms during
menopause?
A) Elevated estrogen levels
B) Decreased estrogen leading to a narrowed thermoregulatory set point
C) Increased progesterone
D) Rising FSH levels
Correct Answer: B
Rationale: Vasomotor symptoms like hot flashes result from estrogen
deficiency, which narrows the thermoregulatory zone in the hypothalamus.
Slight increases in core body temperature are then perceived as excessive
heat, triggering sweating and vasodilation .
Question 2: A 52-year-old woman with a history of breast cancer has 8 hot
flashes daily. What is the first-line non-hormonal therapy recommended by
NAMS?
, A) Vitamin E
B) SSRIs or SNRIs
C) Gabapentin
D) Black cohosh
Correct Answer: B
Rationale: SSRIs (like paroxetine) and SNRIs are recommended as first-line
non-hormonal treatments for moderate-to-severe VMS, especially in
women with contraindications to hormone therapy .
Question 3: Which strategy helps reduce VTE risk with hormone therapy?
A) Using oral estrogen
B) Using transdermal estrogen
C) Adding a progestogen
D) Lowering the dose of progestogen
Correct Answer: B
Rationale: Transdermal estrogen avoids first-pass hepatic metabolism,
resulting in a lower impact on coagulation factors and a lower VTE risk
compared to oral estrogen .
Question 4: A woman in late perimenopause has 60+ day intervals
between periods. What is the expected endometrial thickness on TVUS in
the absence of abnormal bleeding?
A) Greater than 16 mm
, B) Less than 5 mm
C) 4-8 mm
D) Greater than 10 mm
Correct Answer: C
Rationale: In perimenopausal women without abnormal bleeding, an
endometrial thickness of 4-8 mm is generally considered normal and does
not require further evaluation .
Question 5: The "climacteric phase" refers to:
A) The final menstrual period
B) The period of endocrinologic and psychologic changes around the time
of menopause
C) The perimenopause only
D) The postmenopausal period
Correct Answer: B
Rationale: The climacteric phase encompasses the transition from the
reproductive to the non-reproductive stage, including the endocrinologic,
somatic, and psychologic changes that occur .
Question 6: What is the median age of natural menopause?
A) 45 years
B) 48 years
C) 51 years
, D) 55 years
Correct Answer: C
Rationale: The median age of natural menopause is approximately 51
years .
Question 7: Which is the most effective treatment for moderate-to-severe
hot flashes?
A) Calcium
B) Hormone therapy
C) Iron supplements
D) Antibiotics
Correct Answer: B
Rationale: Estrogen therapy is the most effective treatment for vasomotor
symptoms .
Question 8: Which laboratory finding supports menopause?
A) Low FSH
B) Elevated FSH (≥25 IU/L)
C) High progesterone
D) High prolactin
Correct Answer: B
Rationale: Elevated FSH reflects reduced ovarian feedback due to low
estrogen levels and is a useful marker supporting menopause .
